GMJ

Prof. Giorgi Pkhakadze, MD, MPH, PhD

MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
Follow:
2000 Articles

Genital herpes cases rise in England despite overall STI decline

New UK Health Security Agency data show genital herpes diagnoses increasing in England even as most other STIs decline. Young…

UK Grants 847 Parallel Import Licences in 2026 to Address Medicine Shortages

UK regulators granted 847 parallel import licences in 2026 to address medicine shortages. This regulatory mechanism enables importation of medicines…

Federal lawsuits reveal widespread medical neglect in US immigration detention facilities

Federal lawsuits across 33 US states document allegations of medical neglect in immigration detention facilities. Investigation reveals untreated cancers, infections,…

Nevada’s Medical Meal Program Cuts Healthcare Costs by 11% in Medicaid Population

Nevada's medical meal delivery program reduced healthcare costs by 11% among Medicaid beneficiaries with chronic conditions. Emergency department visits fell…

Thymus Health May Predict Longevity and Cancer Survival, AI Study Finds

AI analysis of CT scans reveals that thymus health strongly correlates with longevity, cancer survival, and cardiovascular outcomes. The research…

Rising Transport Costs Reduce UNICEF’s Capacity to Deliver Child Healthcare Supplies

Rising global transport costs are forcing UNICEF to reduce procurement of essential medical supplies for children. The crisis affects vaccines,…

Savolitinib Shows Promise for MET-Amplified Gastric Cancer in Phase 2 Trial

A phase 2 trial shows promising clinical efficacy for savolitinib in treating patients with MET-amplified gastric or gastroesophageal junction adenocarcinoma.…

Molecular Switch Driving Alzheimer’s Brain Inflammation Identified by Scripps Research

Scripps Research scientists have identified a molecular switch involving STING protein modifications that drives chronic brain inflammation in Alzheimer's disease.…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network